SNM Board of Directors
September 18, 2011
Members in Attendance:
George Segall, MD; Fred Fahey, DSc; Gary Dillehay, MD, FACNM; Richard Noto, MD; Dominique
Delbeke, MD, PhD; Ann Marie Alessi, BS, CNMT, NCT, RT(N); Brenda King, CNMT, FSNMTS; Carolyn
Anderson, PhD; Bennett Greenspan, MD; Peter Herscovitch, MD; Hossein Jadvar, MD, PhD, MPH, MBA;
Tony Knight, MBA, CNMT, RT(N), NCT; Cindi Luckett-Gilbert, MHA, CNMT, FSNMTS; Michael Middleton,
MD; Peter Conti, MD, PhD; Virginia Pappas, CAE; Harvey Ziessman, MD
Members Not in Attendance:
Munir Ghesani, MD; Jeff Norenberg, PharmD; Martin Sandler, MD
SNM Staff in Attendance:
Vince Pistilli, CPA; Nikki Wenzel-Lamb, MBA; Judy Brazel; Joanna Spahr, Pam Colman, Sue Bunning,
Marybeth Howlett, Bonnie Clarke, Rebecca Maxey, Bob Milanchus, Christine Cachuela, Al Luckett, Jenny
Mills, Sabrina Robinson
1. Welcome and Call to Order
George Segall, MD, SNM President, called the SNM Board of Directors meeting to order at 8:14 AM.
Richard Noto, MD, SNM Secretary/Treasurer confirmed a quorum was present.
a. Approval of Agenda
Dr. Segall requested approval of the meeting agenda.
A motion was made to approve the agenda as presented.
It was moved, seconded and voted to approve the meeting agenda.
b. Approval of Standing Rules
Dr. Segall reviewed the Standing Rules:
Discussion is limited to 20 minutes per topic
Roberts Rules of Order will be followed.
A motion was made to approve the Standing Rules.
It was moved, seconded and voted to approve the Standing Rules.
2. 2020 Task Force
Dr. Segall provided an overview of the purpose of the task force; to bring together a broad cross
section of health care professionals to discuss the future of our profession and our Society, and make
recommendations that will serve as guiding principles to meet the challenges that lie ahead. Dr.
Segall also reviewed a compilation of the strengths, weaknesses, opportunities and threats (SWOT)
1. Knowledge and application of the tracer principle to assess physiology and molecular
pathways that have resulted in advancement of the field and improvement of health
2. Research, especially the integration of science and clinical practice of NM/MI that advances
3. Education that promotes quality in clinical practice, including diagnosis and therapy
4. Diversity of membership that promotes collaboration among professionals
1. Small size and poor job market coupled with other negative economic forces that decrease the
number of NM/Mi professionals and the effectiveness of professional organizations
2. Multiple professional organizations who have different visions that result in competition instead of
3. Lack of knowledge and understanding about the value of NM by patients, referring physicians,
payers, and agencies that decreases access to care and limits growth of the field
4. Slow government (FDA, CMS) approval process for new radiopharmaceuticals that discourages
1. Incorporation of non-nuclear technologies into NM and evolution of field into a broader based
discipline of MI that is based on the tracer principle rather instrumentation
2. Improve training of young professionals
3. Advance quality of clinical practice
1. Economics, reimbursement, healthcare reform
The 2020 Task Force reviewed six scenarios and agreed that the best scenario would be if nuclear
medicine remained a primary specialty evolving into a broader based discipline of molecular imaging,
with partnerships and collaboration as necessary. However, the most likely scenario was that the field
is advanced by dual certified (ABNM/ABR or other) professionals, who practice the broad based
discipline of molecular imaging.
Dr. Segall reviewed the guiding principles associated with the vision for 2020.
1. Emphasis on continuing education and qualifications of current professionals considering new job
2. Undertake global initiatives
3. Focus on Partnerships
4. Continue to evolution of molecular imaging
Dr. Noto informed the Board of Directors that the time limit had been reached for discussion.
A motion was made to continue the discussion another 20 minutes.
The motion failed.
A motion was made to approve the output of the task force in the form of the two scenarios. The best
scenario is nuclear medicine remains a primary specialty evolving into a broader based discipline of
molecular imaging, with partnerships and collaboration as necessary. The most likely scenario is that
the field is advanced by dual certified (ABNM/ABR or other) professionals, who practice the broad
based discipline of molecular imaging.
It was moved, seconded and voted unanimously to approve the output of the task force in the
form of the two scenarios. The best scenario is nuclear medicine remains a primary specialty
evolving into a broader based discipline of molecular imaging, with partnerships and
collaboration as necessary. The most likely scenario is that the field is advanced by dual
certified (ABNM/ABR or other) professionals, who practice the broad based discipline of
Dr. Segall will begin drafting a white paper that will outline the findings of the 2020 Task Force, as
well as the final recommendation and suggested plan moving forward. The outline of the white paper
will be presented to the Board of Directors during the Mid-Winter Meeting in 2012.
3. Nuclear Medicine Training
Dominique Delbeke, MD, PhD explained that the SNM and ACR created the Joint Task Force II,
chaired jointly by an ACR and SNM representative. The charge of the task force was to offer a
practical solution for joint training between radiology and nuclear medicine as well as review other
training issues identified by Task Force I.
All the organizations support the idea of dual training, but what the ACR co-chair envisions is a
diagnostic radiology, nuclear radiology strategy, rather than diagnostic radiology and nuclear
medicine. The Task Force has been put on hold, for now, pending the SNM Board discussion on what
to do next.
Board members agreed to continue to leave the task force on hold until the SNM Leadership is able
to schedule a meeting with the ACR leadership. During the meeting the leadership will inform ACR of
the 2020 Task Force goal and the scenario and explain that in order to move forward, both groups
need to work to develop programs that support all individuals. If the ACR leadership is amendable to
that, then the task force can be reconstituted.
4. Name Change Task Force
Carolyn Anderson, PhD, provided some background on how the name change task force was formed.
During the 2011 Annual Meeting the House of Delegates discussed the proposed name change, and
reviewed the comments provided by the SNM membership prior to the meeting.
5. Awards Committee
Dr. Delbeke provided an overview of the proposed grants and awards for FY2012. There were three
new awards introduced this year for molecular imaging (one of which is a technologist award).
A motion was made to approve the SNM FY2012 Awards Slate.
It was moved, seconded and voted unanimously to approve the FY2012 Awards Slate.
Peter Conti, MD, PhD, ERF President, requested that the final awards programs be submitted to ERF
at the time the invoice is submitted.
6. Procedure Guidelines Committee
Dr. Delbeke presented the Practice Guideline for Parathyroid Scintigraphy V4.0.
A motion was made to approve of the revised SNM Practice Guideline for Parathyroid Scintigraphy
It was moved, seconded and voted to approve the SNM Practice Guideline for Parathyroid
Dr. Delbeke explained that SNM tries to work with ACR on joint guidelines, when appropriate. The
Board discussed the importance of having both the joint guideline and the SNM guideline. ACR
submitted a letter to the SNM expressing their concerns with SNM continuing to use their guideline, in
addition to the joint guideline. Dr. Delbeke reviewed a draft response and requested approval from
the SNM Board of Directors to send the response to the ACR. The Board of Directors agreed that it
was appropriate to continue to use the joint guidelines as well as the SNM guidelines and approved
sending the letter to ACR.
7. Education and Research Foundation
Dr. Conti reported that ERF had a very successful year in fundraising, including a gift from Bob
Henkin in support of a new award themed around government relations. In addition, it was reported
that $5,000 has been raised for the SNMTS Chapter Roadshow program and Scott Holbrook and Val
Cronin (SNMTS Representatives) are continuing their efforts to garner support.
Over the past several months, ERF has developed a series of policy letters that have distributed to
the SNM Board of Directors. New policies include; a cap on indirect expenses, standards regarding
the amount of grant funding distributed to SNM (for the SNM grants and awards program), and the
creation of a special project fund. Dr. Conti reviewed these new policies with the Board.
8. New Business
Dr. Conti noted that there may be a member who is involved with the society that has a real or
perceived conflict of interest regarding an existing program. Dr. Segall requested Dr. Conti provide
specific information by email so the issue can be addressed.
A motion was made to adjourn the meeting at 1:13pm (ET).
It was moved, seconded and voted to adjourn the meeting at 1:13pm (ET).